Merakris Therapeutics INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersHillsborough, NC
US patents2
SAM.gov UEIE55DU16Y1VN7
CAGE code13HN2
Incorporated inDE
- cell-free wound care therapeutics
- biological drugs
- Dermacyte AC Matrix
- Opticyte Matrix
- human amniotic membranes
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
2 US patents granted 2022–2023, 2 of them in the five years to SEP 2025.
Pharmaceuticals 2
- Compositions containing amniotic components and methods for preparation and use thereofUS 11,590,175 · granted FEB 28, 2023
- Compositions containing amniotic components and methods for preparation and use thereofUS 11,344,583 · granted MAY 31, 2022
Granted to Merakris Therapeutics LLC · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Merakris Therapeutics INC | Hillsborough | NC | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.